Sugar-eating microbes dominate industrial fermentation today. But algae will be the “predominant biomanufacturing platform of tomorrow,” predicts Australian startup Provectus Algae, which is unlocking the potential of photosynthetic algae to make high-value ingredients.
Shiru has identified plant proteins that can be combined with unsaturated oils to create a solid fat that can replace highly saturated animal or tropical fats such as palm and coconut oil.
As news about Silicon Valley Bank rippled through the exhibition halls at Expo West on Friday, AFN walked the show floor to catch up with key players in foodtech, from Climax Foods, showcasing the next generation of plant-based cheese, to Eat Just, which is taking “critical steps towards profitability.”
Thanks to advances in synthetic biology, startups are now programming microbes to express everything from egg albumin without chickens to whey protein without cows. But when animal products are no longer made by animals, what do we call them?
Future Fields has raised US $11.2 million to scale up fruit flies as production vehicles for high value ingredients including growth factors for cultivated meat production and human recombinant proteins for medical research and biopharmaceuticals.
Biomaterials startup Loliware has already scaled its alt-plastic straw made from seaweed and will introduce other products in the near future.
Nine foodtech startups—from animal-free dairy companies to firms making meaty flavors for meat alternatives—have joined forces to create a new trade association: the Precision Fermentation Alliance.
Michroma will use the funds to commercialize its line of natural, fungi-derived food colorants before moving on to flavors, fragrances and more.
Synonym connects precision fermentation startups with production infrastructure to help them unlock the promise of synthetic biology.
The partnership to co-produce automotive designs using mycelium-based products is MycoWorks’ first partnership outside the fashion world.
The San Francisco startup says it has found a way to bring down the cost of cultivated meat manufacturing with biotechnology and machine learning.
The company aims to produce a new class of biomaterials and reduce fashion’s carbon footprint with its “microbial weaving” tech.
Greenlight Biosciences develops RNA products for agriculture and human health, including in the Covid-19 vaccine arena.
The US company’s e-commerce portal provides a more efficient way to source proteins for novel food ingredients, drug discovery, and more.
The New York-based company plans to scale up production of its fermented bio-textile called Mirai.
The San Diego startup makes ingredients for food, cosmetics, and therapeutics “in a cleaner way and a much better way for the planet,” according to co-founder Nicholas Brideau.
Biomanufacturing is the term used to describe the process of using biological systems as opposed to chemistry to produce commercial biomaterials. Crudely this means using certain microbes — naturally-occurring species or genetically designed — to produce certain materials.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first